AUPO161196A0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
AUPO161196A0
AUPO161196A0 AUPO1611A AUPO161196A AUPO161196A0 AU PO161196 A0 AUPO161196 A0 AU PO161196A0 AU PO1611 A AUPO1611 A AU PO1611A AU PO161196 A AUPO161196 A AU PO161196A AU PO161196 A0 AUPO161196 A0 AU PO161196A0
Authority
AU
Australia
Prior art keywords
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPO1611A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Commonwealth Scientific and Industrial Research Organization CSIRO
Original Assignee
Commonwealth Scientific and Industrial Research Organization CSIRO
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Commonwealth Scientific and Industrial Research Organization CSIRO filed Critical Commonwealth Scientific and Industrial Research Organization CSIRO
Priority to AUPO1611A priority Critical patent/AUPO161196A0/en
Publication of AUPO161196A0 publication Critical patent/AUPO161196A0/en
Priority to EP97934376A priority patent/EP1012172A4/en
Priority to AU37619/97A priority patent/AU3761997A/en
Priority to CA002263789A priority patent/CA2263789A1/en
Priority to PCT/AU1997/000511 priority patent/WO1998006743A1/en
Priority to JP50923598A priority patent/JP2001505541A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0819—Tripeptides with the first amino acid being acidic

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AUPO1611A 1996-08-13 1996-08-13 Novel compounds Abandoned AUPO161196A0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
AUPO1611A AUPO161196A0 (en) 1996-08-13 1996-08-13 Novel compounds
EP97934376A EP1012172A4 (en) 1996-08-13 1997-08-13 Acylated peptide cytolytic peptide inhibitors
AU37619/97A AU3761997A (en) 1996-08-13 1997-08-13 Acylated peptide cytolytic peptide inhibitors
CA002263789A CA2263789A1 (en) 1996-08-13 1997-08-13 Acylated peptide cytolytic peptide inhibitors
PCT/AU1997/000511 WO1998006743A1 (en) 1996-08-13 1997-08-13 Acylated peptide cytolytic peptide inhibitors
JP50923598A JP2001505541A (en) 1996-08-13 1997-08-13 Acylated peptide cytolytic peptide inhibitor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPO1611A AUPO161196A0 (en) 1996-08-13 1996-08-13 Novel compounds

Publications (1)

Publication Number Publication Date
AUPO161196A0 true AUPO161196A0 (en) 1996-09-05

Family

ID=3795925

Family Applications (1)

Application Number Title Priority Date Filing Date
AUPO1611A Abandoned AUPO161196A0 (en) 1996-08-13 1996-08-13 Novel compounds

Country Status (5)

Country Link
EP (1) EP1012172A4 (en)
JP (1) JP2001505541A (en)
AU (1) AUPO161196A0 (en)
CA (1) CA2263789A1 (en)
WO (1) WO1998006743A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2959992A1 (en) * 2010-05-11 2011-11-18 Univ Claude Bernard Lyon PEPTIDES WITH ANTIPROTEASE ACTIVITY

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2659114A1 (en) * 1976-12-28 1978-07-06 Troponwerke Gmbh & Co Kg Dehydro-oligopeptide cpds. - useful for treatment of tumours
CA1141374A (en) * 1978-07-03 1983-02-15 Charles H. Stammer Preparation of dehydropeptides
FR2482961A2 (en) * 1979-06-29 1981-11-27 Rhone Poulenc Ind Merrifield synthesis of immunostimulant tetra- and penta-peptide(s) - acylated with fatty acid gps. e.g. N-alpha N,N-hexanoyl-L-alanyl gamma-D-glutamyl N-epsilon-glycyl-L-lysine
FR2460290A1 (en) * 1979-06-29 1981-01-23 Rhone Poulenc Ind NOVEL TETRA- OR PENTAPEPTIDES, THEIR PREPARATION AND THE MEDICINES THAT CONTAIN THEM
FR2482958A2 (en) * 1979-06-29 1981-11-27 Rhone Poulenc Ind Immunostimulant and adjuvant L-alanyl-D-glutamyl tri:peptide derivs. - in which the C-terminal aminoacid is l-lysine or di:amino-pimelic acid and which has a fatty acid n-acyl gp.
DK156252C (en) * 1979-07-31 1989-12-18 Fujisawa Pharmaceutical Co METHOD OF ANALOGUE FOR THE PREPARATION OF DI, TRIAL OR TETRAPEPTIDE DERIVATIVES OR SALTS THEREOF
US4283328A (en) * 1979-10-01 1981-08-11 Research Corporation Preparation of dehydropeptides
FR2496654A1 (en) * 1980-12-19 1982-06-25 Rhone Poulenc Sante NOVEL TRI-, TETRA- AND PENTAPEPTIDES, THEIR PREPARATION AND THE MEDICINAL PRODUCTS CONTAINING SAME
JPS5821645A (en) * 1981-07-29 1983-02-08 Komatsu Seiren Kk Recovery of terephthalic acid
JPS59172445A (en) * 1983-03-19 1984-09-29 Fujisawa Pharmaceut Co Ltd Glutamic acid-containing peptide
US4584284A (en) * 1985-01-31 1986-04-22 Ortho Pharmaceutical Corporation Bursopoietin
ES8702436A1 (en) * 1986-02-11 1986-12-16 Consejo Superior Investigacion Ionic surfactant prepn.
ES2020148A6 (en) * 1990-06-07 1991-07-16 Consejo Superior Investigacion Procedure for the synthesis of dipeptides from fatty chain N-[alpha]-acyl arginine and pure amino acids as ionic surfactants with antimicrobial action
ATE128984T1 (en) * 1990-07-12 1995-10-15 Degussa NEW N-ACYLDIPEPTIDES AND THEIR USE.
YU183090A (en) * 1990-09-27 1992-12-21 Lek NEW N-ACYLDIPEPTIDES, PROCEDURES FOR THEIR PREPARATION AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM
ATE176239T1 (en) * 1990-11-21 1999-02-15 Iterex Pharma Lp SYNTHESIS OF EQUIMOLAR MIXTURES OF VARIOUS OLIGOMERS, SPECIFICALLY OLIGOPEPTIDE MIXTURES
EP0500332B1 (en) * 1991-02-19 1998-05-27 National Food Research Institute Ministry Of Agriculture, Forestry And Fisheries Novel acylamino acid compounds and a method for their production
ATE195948T1 (en) * 1991-05-16 2000-09-15 Warner Lambert Co ENDOTHELIN ANTAGONISTS
JPH05208914A (en) * 1991-09-03 1993-08-20 Fujisawa Pharmaceut Co Ltd Medicinal composition containing peptide compound
ES2114061T3 (en) * 1992-07-29 1998-05-16 Merrell Pharma Inc LUNG PEPTIDIC SURFACTANTS AND THERAPEUTIC COMBINATIONS.
EP0604945A1 (en) * 1992-12-28 1994-07-06 Takeda Chemical Industries, Ltd. TAN-1511, its derivatives, production and use thereof

Also Published As

Publication number Publication date
EP1012172A1 (en) 2000-06-28
CA2263789A1 (en) 1998-02-19
EP1012172A4 (en) 2000-06-28
WO1998006743A1 (en) 1998-02-19
JP2001505541A (en) 2001-04-24

Similar Documents

Publication Publication Date Title
AU5703398A (en) Novel compounds
AU3382595A (en) Novel compounds
AU1251797A (en) Novel heteroaryl-oxazolidinones
AU7210598A (en) Novel compounds
AU6804098A (en) Triazinylaminostilbene compounds
AUPN842196A0 (en) New compound
AU4514496A (en) Novel compounds
AU4925697A (en) Compounds
AUPN955596A0 (en) New compound
AU3620297A (en) Substituted triazoloazinesulphonamides
AUPO941497A0 (en) Novel compounds
AU7124598A (en) Polymer-platinum compounds
AU5423298A (en) Novel compounds
AU3771497A (en) Substituted p-trifluoromethylphenyluracils
AUPO062696A0 (en) Novel compounds
AUPO381496A0 (en) New compound
AU1926397A (en) Substituted 1-methyl-3-benzyluracils
AU4399396A (en) Compounds
AUPO440596A0 (en) New compound
AU8019998A (en) Fluoromethoximino compounds
AU3711697A (en) Novel compounds
AU3856995A (en) UCF116 Compounds
AU3873697A (en) Novel aryl-pyridazines
AU4326397A (en) Novel arylsulfotransferase
AUPO371596A0 (en) New compound